Reading size

PACK IN HAND · ONE-PAGE CHECK

Medicine pack check sheet

Print this sheet or fill it in before speaking with a pharmacist or clinician. Copy only what is printed on the pack in hand. The published fields below are starting points from this record, not proof that your pack is the same product.

Published record starting point

Record display name
Spiriva HandiHaler
Generic name / active ingredient
tiotropium bromide
Dosage-form class
Dosage form and presentation as documented in the linked primary label
Route
Oral inhalation
Record reviewed
2026-08-17

Copy from the pack in hand

Source-linked reading points

  • The FDA label explicitly says SPIRIVA capsules are only for oral inhalation through the HandiHaler device and must not be swallowed. Seeing an “18 mcg capsule” does not make it an oral medicine or interchangeable with any swallowed capsule.
  • The label contains product-specific device information. This page does not repeat or generate an inhalation count, device steps or individual-use instructions. Do not apply steps for another inhaler, nebuliser or “similar capsule” to this product; ask a pharmacist or clinician to demonstrate with the actual device.
  • The label describes long-term maintenance treatment and says it is not for relief of acute bronchospasm. Sudden or worsening breathing difficulty is not a situation for self-escalation, substitution or waiting for a webpage; follow local emergency and care-team guidance.
  • Capsule colour, blister, device appearance and “18 mcg” are only identification clues for this product. They cannot authenticate it, show it is RESPIMAT or another tiotropium product, or prove interchangeability. Have a pharmacist check the actual pack, device, brand name and target market together.

Reviewed presentation examples — compare every field

  • Tiotropium bromide 18 mcg per inhalation capsule; 30 capsules + 1 HandiHaler device (for inhalation only, not swallowing)NDC 0597-0075-41

EDITORIAL RECORD

Who prepared and checked this page

Byline
OriginDrug Content Editorial
Review role
Public primary-source verification
Last reviewed
2026-08-17
Source record
3 clickable primary-source entry points are listed with this dossier.

The review role checks source traceability, stated market, document version and product-identity fields. It is not a claim of clinical licensure, prescribing authority or individual pharmacy service. Read the editorial policy.

Search records
Enlarged public-label image